课题基金 / 基金详情

Alzheimer's Disease and Impaired APP Proteolysis

Alzheimer's Disease and Impaired APP Proteolysis
阿尔茨海默病和 APP 蛋白水解受损
批准号:
6960182
负责人:
Warren C LADIGES
金额:
$16.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-01 至 2007-08-31

项目摘要

项目成果

Warren C LADIGES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Familial Alzheimer's Disease (FAD) is a genetically heritable dominant disorder. Specific missense mutations that result in a single amino acid substitution in p-amyloid precursor protein (APR) have been linked with FAD. FAD mutations in APP cluster around two regions, the extracellular domain adjacent to the a- and (3-secretase sites, and within the intramembranous region adjacent to known y-secretase cleavage sites. The goal of this proposal is to study the effects of FAD mutations upon y-secretase mediated cleavage of APP in the brains of intact mice. The approach involves the development of a trarisgenic mouse model employing a y-secretase activity reporter system previously developed and validated in vitro. Using this screen in cell culture systems, we have demonstrated that FAD mutations result in a decrement in liberation of the APP carboxy-terminus resulting from APP cleavage. While this data is compelling, it remains to be tested whether decrements in y-secretase-mediated APP cleavage are a common effect of FAD mutations within intact brain. This project will test the hypothesis that FAD mutations decrease y-secretase- mediated proteolytic liberation of the carboxy-terminal fragment of APP from the membrane in brain under physiological conditions. The Specific Aims are: 1) Develop a transgenic reporter mouse model to assay y-secretase activity in vivo. Transgenic mouse lines will be developed expressing the APP-Ga!4VP16 activator under the control of the elongation factor 1 alpha (EF1a) promoter, and crossed with Gal4- luciferaseEGFP transgenic mice. Successful deployment of the genetic screening system, and the y-secretase dependency of the reporter output, will be validated by histological and reporter assay methods. 2) Compare y-secretase-mediated cleavage of wild-type and FAD mutant APP-Gal4VP16 using the transgenic reporter mouse model. FAD mutant APP-Gal4VP16 transgenic lines will be crossed with Gal4- luciferaseEGFP reporter mice, and comparative analysis of the reporter output of the wild-type and FAD mutants will be used to determine relative y-secretase activity in each set of transgenic: lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Physical resilience is a predictor of healthy aging
  • 批准号:
    10731992
  • 项目类别:
  • 资助金额:
    $67.3万
  • 财政年份:
    2017
  • 负责人:
    Warren C LADIGES
  • 依托单位:
Physical resilience is a predictor of healthy aging in mice
  • 批准号:
    9418968
  • 项目类别:
  • 资助金额:
    $31.78万
  • 财政年份:
    2017
  • 负责人:
    Warren C LADIGES
  • 依托单位:
Physical resilience is a predictor of healthy aging in mice
  • 批准号:
    10166752
  • 项目类别:
  • 资助金额:
    $31.78万
  • 财政年份:
    2017
  • 负责人:
    Warren C LADIGES
  • 依托单位:
Pathology of Aging Research Network
  • 批准号:
    9063461
  • 项目类别:
  • 资助金额:
    $38.63万
  • 财政年份:
    2014
  • 负责人:
    Warren C LADIGES
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究